Find clinical trials for Endometrial Cancer in Louisville, KY

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Carcinoma

Cancer

Ovarian Cancer

Breast Cancer

Ovarian Epithelial Carcinoma

Triple Negative Breast Cancer

Lung Cancer

Endometrial Cancer trials near Louisville, KY, USA:

Status recently updated

A Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer

Study RGX-104-001 is a Phase 1, first-in-human, dose escalation and expansion study of RGX-104, an oral small molecule targeting the liver X receptor...

Enrolling

Active, not recruiting

Endometrial Cancer

Lung Cancer

Drug: Pembrolizumab

Drug: RGX-104

Phase 1

Inspirna

Louisville, Kentucky, United States of America and 20 other locations

Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer (DUO-E)

(paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial...

Active, not recruiting

Endometrial Neoplasms

Drug: Carboplatin

Biological: durvalumab

Phase 3

AstraZeneca

Louisville, Kentucky, United States and 202 other locations

A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors

preliminary antitumor activity of NKT3447 in adult subjects with cyclin E1 (CCNE1) amplified ovarian cancer at the RDEs selected in Dose Es...

Enrolling

Platinum-resistant Ovarian Cancer

Endometrial Cancer

Drug: NKT3447

Phase 1

NiKang Therapeutics

Louisville, Kentucky, United States and 6 other locations

Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)

The purpose of this study is to compare pembrolizumab + adjuvant chemotherapy with placebo + adjuvant chemotherapy, with or without radiotherapy, wit...

Active, not recruiting

Endometrial Neoplasms

Drug: Placebo for pembrolizumab

Drug: Cisplatin (as radiosensitizer)

Phase 3

Merck Sharp & Dohme (MSD)

Louisville, Kentucky, United States and 230 other locations

TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers

TTX-080-001 is a Phase 1, open label, dose escalation and dose expansion clinical study to determine the safety, tolerability, and recommended Phase...

Active, not recruiting

Cancer

Drug: pembrolizumab

Drug: TTX-080

Phase 1

Tizona Therapeutics

Louisville, Kentucky, United States and 39 other locations

GEN1046 Safety Trial in Patients With Malignant Solid Tumors

The purpose of the trial is to evaluate the safety of acasunlimab (also known as GEN1046) as monotherapy and in combination therapies in patients wit...

Active, not recruiting

Endometrial Carcinoma

Non-small Cell Lung Cancer

Biological: Acasunlimab in combination with pembrolizumab (in a separate expansion cohort)

Biological: Acasunlimab in combination with docetaxel (in a single expansion cohort)

Phase 1, Phase 2

Genmab

Louisville, Kentucky, United States and 56 other locations

Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer

Determine the safety, tolerability, pharmacokinetics, maximum tolerated dose (MTD) and recommended phase 2 dose (RP2D) of VIP152 (BAY 1251152) as mon...

Active, not recruiting

Neoplasms

Drug: VIP152 (BAY 1251152) 30 mg

Drug: VIP152 (BAY 1251152) 15 mg

Phase 1

Vincerx Pharma

Louisville, Kentucky, United States and 15 other locations

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources